Listed

Staar Surgical Co: Form 10-K for the period ended Jan 3, 2020

Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 26, 2020, 16:17 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-01-03. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-09-28 to 2020-01-03$38.9mus-gaap:Revenues
Revenue12 months2018-12-29 to 2020-01-03$20.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2018-12-29 to 2020-01-03$38.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-09-28 to 2020-01-03$28.8mus-gaap:GrossProfit
Gross profit12 months2018-12-29 to 2020-01-03$112.0mus-gaap:GrossProfit
Research and development12 months2018-12-29 to 2020-01-03$25.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2018-12-29 to 2020-01-03$100.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2018-12-29 to 2020-01-03$11.9mus-gaap:OperatingIncomeLoss
Income tax12 months2018-12-29 to 2020-01-03−$1.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-09-28 to 2020-01-03$6.4mus-gaap:NetIncomeLoss
Net income12 months2018-12-29 to 2020-01-03$14.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-09-28 to 2020-01-03$0.14us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2018-12-29 to 2020-01-03$0.30us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-09-28 to 2020-01-03$0.14us-gaap:EarningsPerShareBasic
Basic EPS12 months2018-12-29 to 2020-01-03$0.32us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2018-12-29 to 2020-01-0346,895,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2018-12-29 to 2020-01-03$25.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-12-29 to 2020-01-03$10.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-01-03$120.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-01-03$174.7mus-gaap:AssetsCurrent
Total assetsAt period end2020-01-03$206.9mus-gaap:Assets
Current liabilitiesAt period end2020-01-03$34.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-01-03$47.0mus-gaap:Liabilities
Shareholders' equityAt period end2020-01-03$159.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-006791. Last ingested by Listed: Nov 4, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.